594839-88-0
Product Name:
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
Formula:
C14H7Cl2NO3
Inquiry
CHEMICAL AND PHYSICAL PROPERTIES
| Solubility | >50mg/mL |
|---|
COMPUTED DESCRIPTORS
| Molecular Weight | 308.1 g/mol |
|---|---|
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 306.9802985 g/mol |
| Monoisotopic Mass | 306.9802985 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 371 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Tafamidis is a member of the class of 1,3-benzoxazoles that is 1,3-benzoxazole-6-carboxylic acid in which the hydrogen at position 2 is replaced by a 3,5-dichlorophenyl group. Used (as its meglumine salt) for the amelioration of transthyretin-related hereditary amyloidosis. It has a role as a central nervous system drug. It is a member of 1,3-benzoxazoles, a monocarboxylic acid and a dichlorobenzene. It is a conjugate acid of a tafamidis(1-).
RELATED SUPPLIERS
SRINI PHARMACEUTICALS PVT LTD
1Y
product:(2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid) 98%